BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37105900)

  • 21. Long Noncoding RNA PVT1 Silencing Prevents the Development of Uveal Melanoma by Impairing MicroRNA-17-3p-Dependent MDM2 Upregulation.
    Wu S; Chen H; Han N; Zhang C; Yan H
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4904-4914. PubMed ID: 31770435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of differentially expressed metastatic genes and their signatures to predict the overall survival of uveal melanoma patients by bioinformatics analysis.
    Zhao DD; Zhao X; Li WT
    Int J Ophthalmol; 2020; 13(7):1046-1053. PubMed ID: 32685390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of deregulated microRNAs in uveal melanomas.
    Falzone L; Romano GL; Salemi R; Bucolo C; Tomasello B; Lupo G; Anfuso CD; Spandidos DA; Libra M; Candido S
    Mol Med Rep; 2019 Apr; 19(4):2599-2610. PubMed ID: 30816460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic values of Annexins and validation of the influence on cell proliferation, migration, and invasion in uveal melanoma.
    Zhao A; Wang Z; Wang Y; Chen X
    Am J Transl Res; 2023; 15(5):3131-3151. PubMed ID: 37303667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of long noncoding RNA MALAT1 inhibits the development of uveal melanoma via microRNA-608-mediated inhibition of HOXC4.
    Wu S; Chen H; Zuo L; Jiang H; Yan H
    Am J Physiol Cell Physiol; 2020 May; 318(5):C903-C912. PubMed ID: 31913701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Necroptosis-Related Prognostic Model of Uveal Melanoma Was Constructed by Single-Cell Sequencing Analysis and Weighted Co-Expression Network Analysis Based on Public Databases.
    Xie J; Chen L; Tang Q; Wei W; Cao Y; Wu C; Hang J; Zhang K; Shi J; Wang M
    Front Immunol; 2022; 13():847624. PubMed ID: 35242144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic and Functional Analysis of
    Mei S; Li Y; Kang X
    Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a novel immune-related gene signature for prognosis and the tumor microenvironment in patients with uveal melanoma combining single-cell and bulk sequencing data.
    Wang W; Zhao H; Wang S
    Front Immunol; 2023; 14():1099071. PubMed ID: 36793711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-454 functions as an oncogene by regulating PTEN in uveal melanoma.
    Sun L; Wang Q; Gao X; Shi D; Mi S; Han Q
    FEBS Lett; 2015 Sep; 589(19 Pt B):2791-6. PubMed ID: 26296312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of differentially expressed genes and functional annotations associated with metastases of the uveal melanoma.
    Xu Y; Han W; Xu WH; Wang Y; Yang XL; Nie HL; Yao J; Shen GL; Zhang XF
    J Cell Biochem; 2019 Nov; 120(11):19202-19214. PubMed ID: 31270856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-506 inhibits the proliferation and invasion of mantle cell lymphoma cells by targeting B7H3.
    Zhu XW; Wang J; Zhu MX; Wang YF; Yang SY; Ke XY
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1067-1073. PubMed ID: 30553455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Potential Role of Selected miRNA in Uveal Melanoma Primary Tumors as Early Biomarkers of Disease Progression.
    Wróblewska JP; Lach MS; Ustaszewski A; Kulcenty K; Ibbs M; Jagiełło I; Suchorska WM; Marszałek A
    Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32131485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-140-5p is negatively correlated with proliferation, invasion, and tumorigenesis in malignant melanoma by targeting SOX4 via the Wnt/β-catenin and NF-κB cascades.
    Zhao G; Yin Y; Zhao B
    J Cell Physiol; 2020 Mar; 235(3):2161-2170. PubMed ID: 31385607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single cell sequencing analysis constructed the N7-methylguanosine (m7G)-related prognostic signature in uveal melanoma.
    Xie J; Chen L; Cao Y; Ma C; Zhao W; Li J; Yao W; Hu Y; Wang M; Shi J
    Aging (Albany NY); 2023 Mar; 15(6):2082-2096. PubMed ID: 36920166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN.
    Ling JW; Lu PR; Zhang YB; Jiang S; Zhang ZC
    Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator.
    Wang J; Fang Y; Liu YF; Wang X; Wang XL; Wang RY; Meng ZD
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4275-4284. PubMed ID: 31173299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
    Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
    Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma.
    Zhu R; Chen YT; Wang BW; You YY; Wang XH; Xie HT; Jiang FG; Zhang MC
    BMC Cancer; 2023 Feb; 23(1):146. PubMed ID: 36774490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IsomiRs and tRNA-derived fragments are associated with metastasis and patient survival in uveal melanoma.
    Londin E; Magee R; Shields CL; Lally SE; Sato T; Rigoutsos I
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):52-62. PubMed ID: 31283110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.